tiprankstipranks
Peijia Medical Ltd. (DE:4WO)
FRANKFURT:4WO

Peijia Medical Ltd. (4WO) Income Statement

0 Followers

Peijia Medical Ltd. Income Statement

Last quarter (Q2 2022), Peijia Medical Ltd.'s total revenue was ¥―, a decrease of ― from the same quarter last year. In Q2, Peijia Medical Ltd.'s net income was ¥―. See Peijia Medical Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 21Dec 20Dec 19Dec 18
Total Revenue
-¥ 136.53M¥ 38.66M¥ 18.70M¥ 0.00
Cost of Revenue
-¥ 40.88M¥ 13.43M¥ 6.69M¥ 0.00
Gross Profit
-¥ 95.65M¥ 25.22M¥ 12.01M¥ 0.00
Operating Expense
-¥ 645.26M¥ 234.49M¥ 234.28M¥ 71.66M
Operating Income
-¥ -549.60M¥ -209.26M¥ -222.27M¥ -71.66M
Net Non Operating Interest Income Expense
-¥ 24.59M¥ 37.21M¥ 1.33M¥ 75.00K
Other Income Expense
-----
Pretax Income
-¥ -574.22M¥ -2.07B¥ -531.98M¥ -82.88M
Tax Provision
-¥ 0.00¥ 0.00¥ 0.00¥ 0.00
Earnings From Equity Interest Net Of Tax
-----
Net Income Common Stockholders
-¥ -574.22M¥ -2.07B¥ -531.98M¥ -82.63M
Basic EPS
-¥ -0.86¥ -4.43¥ -0.87¥ -0.14
Diluted EPS
-¥ -0.86¥ -4.43¥ -0.87¥ -0.14
Basic Average Shares
-¥ 661.66M¥ 466.99M¥ 610.04M¥ 610.04M
Diluted Average Shares
-¥ 661.66M¥ 466.99M¥ 610.04M¥ 610.04M
Dividend Per Share
-----
Total Operating Income As Reported
-----
Reported Normalized Basic E P S
-----
Reported Normalized Diluted E P S
-----
Rent Expense Supplemental
-----
Total Expenses
-¥ 686.14M¥ 247.92M¥ 240.97M¥ 71.66M
Net Income From Continuing And Discontinued Operation
-¥ -574.22M¥ -2.07B¥ -531.98M¥ -82.63M
Normalized Income
-¥ -574.68M¥ -392.75M¥ -223.51M¥ -74.18M
Interest Expense
-¥ 186.00K¥ 91.00K¥ 823.00K¥ 163.00K
EBIT
-¥ -574.03M¥ -2.07B¥ -531.15M¥ -82.71M
EBITDA
-¥ -546.54M¥ -2.05B¥ -517.82M¥ -77.94M
Currency in CNY

Peijia Medical Ltd. Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis